HCW Biologics Inc. (HCWB)
Nasdaq: HCWB · Pharmaceutical Preparations · Miramar, FL · filing with the SEC since 2020
Filings
232 filings since 2017 beside 109 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 45 days after the quarter ended. The proxy statement was last filed Oct 1, 2026.
Filings a yearinsider forms included
1723942417076
2026 counts to Nov 13, 2026.
Warning not to rely on past financial statements (8-K item 4.02): 2 times in the last 36 months, the newest Aug 14, 2026.Listing warning from its exchange (8-K item 3.01): 10 times in the last 36 months, the newest Jun 30, 2026.Officer or director change (8-K item 5.02): 1 time in the last 36 months, the newest Jun 23, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Sep 20, 2024.SEC letters: 12 in the last 36 months, the newest Aug 28, 2026.A late-filing notice, Form NT 10-Q, filed Aug 15, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026
8-K items 1.01, 7.01, 8.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD); Other event · Current report
Sep 24, 2026
8-K items 1.01, 3.02, 7.01, 8.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD); Other event · Current report
Sep 23, 2026
Sep 10, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Sep 9, 2026
Sep 8, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Sep 4, 2026
Aug 14, 2026
8-K item 4.02
Warning not to rely on past financial statements · Current report
Aug 10, 2026
Jul 29, 2026
8-K items 1.01, 3.02, 7.01, 8.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD); Other event · Current report
Jun 26, 2026
8-K items 3.03, 5.03, 7.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Jun 24, 2026
May 21, 2026
8-K items 1.01, 3.02, 7.01, 8.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD); Other event · Current report
40 of 232 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.